PM

Peter M. Hecht

North America, Massachusetts, United States, Cambridge

Description

Peter Hecht is the Co-Founder and CEO of Cyclerion Therapeutics. He previously worked at Ironwood Pharmaceuticals as a Co-Founder and CEO. P...

Investor Profile

Peter M. Hecht has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Post Ipo Equity (67%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Peter M. Hecht frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Co-Investments: 1
J. Wood Capital Advisors
North America, California, United States, Santa Rosa
Co-Investments: 1
SP
North America, New York, United States, New York
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Venrock
North America, California, United States, Palo Alto
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2
Lincoln Park Capital Fund
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Peter M. Hecht?

Tisento Therapeutics

Cambridge, Massachusetts, United States

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health CareMedicalTherapeutics
Series AJul 31, 2023
Amount Raised: $81,000,000
Cyclerion Therapeutics

Cambridge, Massachusetts, United States

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

BiotechnologyPharmaceutical
Post Ipo EquityMay 25, 2023
Amount Raised: $5,000,000
Cyclerion Therapeutics

Cambridge, Massachusetts, United States

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

BiotechnologyPharmaceutical
Post Ipo EquityJun 4, 2021
Amount Raised: $18,000,000

Find More Investors Like Peter M. Hecht

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Peter M. Hecht | Pipeseed